Chaput N - Search Results

1

Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: surrogate marker of efficacy of tremelimumab?

Ménard C, Ghiringhelli F, Roux S, Chaput N, Mateus C, Grohmann U, Caillat-Zucman S, Zitvogel L, Robert C. Ménard C, et al. Among authors: chaput n. Clin Cancer Res. 2008 Aug 15;14(16):5242-9. doi: 10.1158/1078-0432.CCR-07-4797. Clin Cancer Res. 2008. PMID: 18698043 Clinical Trial.

2

Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.

Ikarashi Y, Mikami R, Bendelac A, Terme M, Chaput N, Terada M, Tursz T, Angevin E, Lemonnier FA, Wakasugi H, Zitvogel L. Ikarashi Y, et al. Among authors: chaput n. J Exp Med. 2001 Oct 15;194(8):1179-86. doi: 10.1084/jem.194.8.1179. J Exp Med. 2001. PMID: 11602646 Free PMC article.

3

From the antigen-presenting cell to the antigen-presenting vesicle: the exosomes.

Schartz NE, Chaput N, André F, Zitvogel L. Schartz NE, et al. Among authors: chaput n. Curr Opin Mol Ther. 2002 Aug;4(4):372-81. Curr Opin Mol Ther. 2002. PMID: 12222875 Review.

4

Tumor-derived exosomes: a new source of tumor rejection antigens.

André F, Schartz NE, Chaput N, Flament C, Raposo G, Amigorena S, Angevin E, Zitvogel L. André F, et al. Among authors: chaput n. Vaccine. 2002 Dec 19;20 Suppl 4:A28-31. doi: 10.1016/s0264-410x(02)00384-5. Vaccine. 2002. PMID: 12477425 Review.

5

Exosomes for immunotherapy of cancer.

Chaput N, Schartz NE, Andre F, Zitvogel L. Chaput N, et al. Adv Exp Med Biol. 2003;532:215-21. doi: 10.1007/978-1-4615-0081-0_17. Adv Exp Med Biol. 2003. PMID: 12908560 Review.

6

[Exosomes and anti-tumour immunotherapy].

Chaput N, Andre F, Schartz NE, Flament C, Angevin E, Escudier B, Zitvogel L. Chaput N, et al. Bull Cancer. 2003 Aug-Sep;90(8-9):695-8. Bull Cancer. 2003. PMID: 14609758 Free article. Clinical Trial. French.

7

Exosome-based immunotherapy.

Chaput N, Taïeb J, Schartz NE, André F, Angevin E, Zitvogel L. Chaput N, et al. Cancer Immunol Immunother. 2004 Mar;53(3):234-9. doi: 10.1007/s00262-003-0472-x. Epub 2004 Jan 16. Cancer Immunol Immunother. 2004. PMID: 14727085 Free PMC article. Review.

8

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.

André F, Chaput N, Schartz NE, Flament C, Aubert N, Bernard J, Lemonnier F, Raposo G, Escudier B, Hsu DH, Tursz T, Amigorena S, Angevin E, Zitvogel L. André F, et al. Among authors: chaput n. J Immunol. 2004 Feb 15;172(4):2126-36. doi: 10.4049/jimmunol.172.4.2126. J Immunol. 2004. PMID: 14764678

9

Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection.

Chaput N, Schartz NE, André F, Taïeb J, Novault S, Bonnaventure P, Aubert N, Bernard J, Lemonnier F, Merad M, Adema G, Adams M, Ferrantini M, Carpentier AF, Escudier B, Tursz T, Angevin E, Zitvogel L. Chaput N, et al. J Immunol. 2004 Feb 15;172(4):2137-46. doi: 10.4049/jimmunol.172.4.2137. J Immunol. 2004. PMID: 14764679

10

IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules.

Terme M, Tomasello E, Maruyama K, Crépineau F, Chaput N, Flament C, Marolleau JP, Angevin E, Wagner EF, Salomon B, Lemonnier FA, Wakasugi H, Colonna M, Vivier E, Zitvogel L. Terme M, et al. Among authors: chaput n. J Immunol. 2004 May 15;172(10):5957-66. doi: 10.4049/jimmunol.172.10.5957. J Immunol. 2004. PMID: 15128777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters